BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38496070)

  • 21. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
    James PA; Oparil S; Carter BL; Cushman WC; Dennison-Himmelfarb C; Handler J; Lackland DT; LeFevre ML; MacKenzie TD; Ogedegbe O; Smith SC; Svetkey LP; Taler SJ; Townsend RR; Wright JT; Narva AS; Ortiz E
    JAMA; 2014 Feb; 311(5):507-20. PubMed ID: 24352797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
    Powers BJ; Coeytaux RR; Dolor RJ; Hasselblad V; Patel UD; Yancy WS; Gray RN; Irvine RJ; Kendrick AS; Sanders GD
    J Gen Intern Med; 2012 Jun; 27(6):716-29. PubMed ID: 22147122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension.
    Akat PB; Bapat TR; Murthy MB; Karande VB; Burute SR
    Indian J Pharmacol; 2010 Jun; 42(3):153-6. PubMed ID: 20871766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study.
    Malacco E; Omboni S; Volpe M; Auteri A; Zanchetti A;
    J Hypertens; 2010 Nov; 28(11):2342-50. PubMed ID: 20829713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
    Heran BS; Wong MM; Heran IK; Wright JM
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003823. PubMed ID: 18843651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.
    Heran BS; Wong MM; Heran IK; Wright JM
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003822. PubMed ID: 18843650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.
    Iravanian S; Dudley SC
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S12-7. PubMed ID: 18456194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
    Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
    Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D; Porteri E; De Ciuceis C; Sleiman I; Rodella L; Rezzani R; Paiardi S; Bianchi R; Ruggeri G; Boari GE; Muiesan ML; Salvetti M; Zani F; Miclini M; Rosei EA
    Hypertension; 2005 Apr; 45(4):659-65. PubMed ID: 15723969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
    Ruilope L; Jäger B; Prichard B
    Blood Press; 2001; 10(4):223-9. PubMed ID: 11800061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
    Flack JM; Saunders E; Gradman A; Kraus WE; Lester FM; Pratt JH; Alderman M; Green S; Vargas R; Espenshade M; Ceesay P; Alexander J; Goldberg A;
    Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.
    Padwal R; Straus SE; McAlister FA
    BMJ; 2001 Apr; 322(7292):977-80. PubMed ID: 11312234
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT; O'Kane KP; Istad H; Keinänen-Kiukaanniemi S; Van Mierlo HF
    J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
    Neutel JM; Frishman WH; Oparil S; Papademitriou V; Guthrie G
    Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group.
    Fogari R; Ambrosoli S; Corradi L; Degli Esposti E; Mos L; Nami R; Nicrosini F; Pessina AC; Salvetti A; Vaccarella A; Zanchetti A; Martin A; Reeves RA
    J Hypertens; 1997 Dec; 15(12 Pt 1):1511-8. PubMed ID: 9431859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.